These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 852547)

  • 1. [Effect of phepracet and its derivatives on the development of neurogenic dystrophy of the stomach wall and the concentration of noradrenaline in it].
    Zabrodin ON; Lapkin VA
    Farmakol Toksikol; 1977; 40(1):56-9. PubMed ID: 852547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological analysis of the participation of serotonin in the central mechanisms of the development of a neurogenic stomach lesion in the rat].
    Bul'on VV
    Farmakol Toksikol; 1988; 51(1):34-7. PubMed ID: 3258827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A pharmacological analysis of the central monoaminergic mechanisms of the development of neurogenic stomach damage].
    Bul'on VV; Khnychenko LK
    Farmakol Toksikol; 1990; 53(2):36-8. PubMed ID: 1973391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of pharmacological substances on the development of hemorrhagic erosions and on the noradrenaline level in the stomach wall in rats].
    Zabrodin ON
    Farmakol Toksikol; 1978; 41(1):32-6. PubMed ID: 23958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of alpha-methyl-p-tyrosine on the development of neurogenic dystrophy in the gastric wall and on its noradrenaline content].
    Zabrodin ON
    Biull Eksp Biol Med; 1975 Jun; 79(6):30-2. PubMed ID: 1222245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of central neurotropic drugs on the development of reflex gastric dystrophy].
    Moreva EV; Zabrodin ON; Shalupnia AS; Repetun IN
    Farmakol Toksikol; 1972; 35(5):603-5. PubMed ID: 4652013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic analysis of the participation of endogenous noradrenaline in the retrograde development of neurogenic gastric dystrophy].
    Zabrodin ON
    Farmakol Toksikol; 1972; 35(5):606-10. PubMed ID: 4652014
    [No Abstract]   [Full Text] [Related]  

  • 8. [Central mechanisms of neurogenic gastric lesion and its pharmacologic correction].
    Bul'on VV
    Patol Fiziol Eksp Ter; 1995; (1):21-3. PubMed ID: 7609999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of L-DOPA on repair of neurogenic dystrophic damage to the gastric mucosa of rats].
    Zabrodin ON; Bertash VI
    Biull Eksp Biol Med; 1976; 82(11):1347-9. PubMed ID: 1087890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of lithium salts on experimental neurogenic lesions of the stomach and heart].
    Kryzhanovskiĭ GN; Zavodskaia IS; Moreva EV
    Biull Eksp Biol Med; 1984 Jun; 97(6):653-5. PubMed ID: 6331544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of adrenergic compounds on the development of experimental neurogenic dystrophy of gastric wall in rats].
    Zabrodin ON
    Farmakol Toksikol; 1967; 30(4):430-3. PubMed ID: 5598895
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastroprotection by pentoxyfilline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines.
    Kwiecień S; Brzozowski T; Konturek PC; Pawlik MW; Pawlik WW; Kwiecień N; Konturek SJ
    J Physiol Pharmacol; 2004 Jun; 55(2):337-55. PubMed ID: 15213357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of l-DOPA on the development of neurogenic dystrophies].
    Zavodskaia IS; Moreva EV; Isachenko VB; Novikova NA; Zaskal'ko NI
    Farmakol Toksikol; 1972; 35(5):595-600. PubMed ID: 4652012
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of neurotropic agents on the healing of experimental mucosal erosions and on the noradrenaline content in the stomach wall].
    Zabrodin ON; Lebedev SN
    Farmakol Toksikol; 1979; 42(5):484-7. PubMed ID: 488317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early signs of neurogenic dystrophy of the stomach wall and the effect of neurotropic substances on them].
    Zavodskaia IS; Manina AA
    Biull Eksp Biol Med; 1967 Mar; 63(3):75-8. PubMed ID: 5622350
    [No Abstract]   [Full Text] [Related]  

  • 16. [The level of histamine and serotonin in the rat stomach wall in the development of neurogenic dystrophy].
    Grechishkin LL; Mustafina TK
    Biull Eksp Biol Med; 1970 Mar; 69(3):31-3. PubMed ID: 5509111
    [No Abstract]   [Full Text] [Related]  

  • 17. [The serotoninergic component in the mechanism of the development of neurogenic damage to the stomach].
    Zavodskaia IS; Bul'on VV
    Farmakol Toksikol; 1987; 50(1):77-80. PubMed ID: 3556557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of DOPA and alpha-methyl-DOPA on the development of neurogenic dystrophy of the gastric wall and catecholamine content of the stomach].
    Zabrodin ON
    Biull Eksp Biol Med; 1970 Jul; 70(7):58-60. PubMed ID: 5501776
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mediator content of the rat brain in neurogenic gastric pathology].
    Zavodskaia IS; Bul'on VV; Moreva EV
    Biull Eksp Biol Med; 1984 Feb; 97(2):135-6. PubMed ID: 6141824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between tocopherol and tocotrienol effects on gastric parameters in rats exposed to stress.
    Azlina MF; Nafeeza MI; Khalid BA
    Asia Pac J Clin Nutr; 2005; 14(4):358-65. PubMed ID: 16326642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.